Financial Services
SWK Holdings Corporation 9.00% Senior Notes due 2027(SWKHL)
Live Price
Offline$25.25
-0.07% today
1Y Change
+1.38%
Window
Jun 23, 2025 โ Jun 12, 2026
- Market Cap
- $190.00M
- Revenue Growth
- -9.4%
- EPS Growth
- -119.3%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 23, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SWK Holdings Corporation 9.00% Senior Notes due 2027 (SWKHL) is a Financial Services stock with a market cap of $190.00M and listed on NASDAQ. The stock last traded around $25.25 and up 1.4% across the available one-year price window (Jun 23, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of -9.4%, EPS growth of -119.3%, a dividend yield of 0.0%. What stands out right now is revenue -9.4%, EPS -119.3%, free cash flow +16.9% with operating margin 58.9% and ROIC -1.1%. Valuation sits in the middle of the pack at price/sales 4.7. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SWKHL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-9.4% vs +3.4% peer median
Operating Margin
Above sector median
+58.9% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 6, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -9.4% and EPS is at -119.3%, with operating margin around 58.9%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.1% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 6, 2026 | โ | +0.0% | -0.4% | -0.1% |
2026 Mar 20, 2026 | -402.9% | +0.0% | +0.2% | +0.9% |
2025 Nov 6, 2025 | +112.2% | +0.0% | +0.5% | +0.8% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SWKHL
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SWKHL Max Drawdown
-2.89%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SWKHL and SPY.
Company Overview
SWK Holdings Corporation 9.00% Senior Notes due 2027
NASDAQ Global Market
SWK Holdings Corporation, a specialty finance company that focuses on the healthcare sector. It operates in two segments, Finance Receivables and Pharmaceutical Development. The company provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. It also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. In addition, the company engages in the pharmaceutical development, formulation and manufacturing, and licensing business through the Peptelligence platform. Further, it intends to out-license its internal product pipeline to create novel formulations using its proprietary technology to develop treatments for patients and caregivers. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was founded in 1996 and is headquartered in Dallas, Texas.
- Leadership
- Jody. D Staggs
- IPO Date
- Oct 4, 2023
- Employees
- 24
- Street Address
- 14755 Preston Road
- Mailing
- Dallas, TX, 75254
- Region
- Dallas, TX, US
- Reporting Currency
- USD
- Investor Line
- 972 687 7250
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 7.3
- Price/Sales
- 4.7
- Price/Book
- 0.8
Growth
- Revenue
- -9.4%
- EPS
- -119.3%
- Free Cash Flow
- +16.9%
Profitability
- Gross Margin
- 95.3%
- Operating Margin
- 58.9%
- Net Margin
- -6.2%
- ROE
- -1.0%
- ROIC
- -1.1%
Balance Sheet
- Debt/Equity
- 0.14
- Current Ratio
- 9.41
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.